Prior to the emergence of new mutants of the coronavirus, such as the British variant B.1.1.7, the SARS-CoV-2 variant named
Read more
protein
Antibody and T cell response to SARS-CoV-2 persist up to 8 months: Study of Ski Resort Ischgl
The first instance of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in Austria was observed in the Ski
Read more
Study reports lasting immune response in convalescent COVID-19 patients
Using different types of assays, researchers found both cellular and humoral immune responses for up to eight months in coronavirus
Read more
KTH researchers identify 300 proteins that regulate cell division process
With the hope of contributing to the fight against cancer, researchers in Sweden have published a new molecular mapping of
Read more
Study identifies potential therapeutic target for treatment of Huntington's disease
Huntington's disease is caused by a mutation in the Huntingtin gene (HTT), which appears in adults and features motor, cognitive
Read more
Cissampelos pareira L. extracts demonstrate anti-SARS-CoV-2 activity in vitro
A team of scientists from India has recently investigated the antiviral potency of a traditional medicinal plant Cissampelos pareira L.
Read more
allied bingo
The onset of the coronavirus disease 2019 (COVID-19) pandemic has brought about an international effort to uncover the biology of
Read more
A pangolin coronavirus spike glycoprotein sheds light on SARS-CoV-2’s evolution
As the coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to wreak havoc
Read more
Clonally expanded plasma cell lineages in SARS-CoV-2 produce specific neutralizing antibodies
The immune response to infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the ongoing coronavirus
Read more
Scientists discover new immunotherapy target for malignant brain tumors
Scientists say they have discovered a potential new target for immunotherapy of malignant brain tumors, which so far have resisted
Read more